Kidney Clinical Research Unit, London Health Sciences Centre, London, Ontario, Canada; Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
Kidney Clinical Research Unit, London Health Sciences Centre, London, Ontario, Canada; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
Am J Kidney Dis. 2015 Oct;66(4):646-54. doi: 10.1053/j.ajkd.2015.03.031. Epub 2015 May 12.
Little is known about vascular access in patients starting hemodialysis therapy after kidney transplant failure.
Retrospective cohort study.
SETTING & PARTICIPANTS: Adult patients (aged ≥18 years) who started hemodialysis therapy in Ontario, Canada, from January 1, 2001, through December 31, 2010, after kidney transplant failure.
Patient clinical and demographic characteristics.
Proportion and timing of arteriovenous (AV) vascular access creation (fistula or graft) 12 months prior and up to 24 months after starting hemodialysis therapy.
Event rates and outcome predictors.
Our cohort included 683 patients with a mean age of 48 years and >50% with comorbidity index score < 3. In the 12 months predialysis and 24 months postdialysis, 16% and 47% of patients had an AV access created, respectively. In the postdialysis period, 13%, 26%, and 38% of patients had an AV access creation at 3, 6, and 12 months, respectively. History of coronary artery disease, diabetes mellitus, and peritoneal dialysis use prior to transplantation were associated with a lower likelihood of AV access creation.
Residual selection bias from unmeasured variables beyond the data elements.
In Ontario, AV access creation, both before and after starting hemodialysis therapy, is low in patients with kidney transplant failure despite their being younger and healthier compared to the overall hemodialysis population. This highlights the need for a predialysis care pathway in the transplantation clinic and an active strategy to identify this patient cohort receiving hemodialysis to align modality and access choices.
在肾移植失败后开始血液透析治疗的患者中,血管通路的情况鲜为人知。
回顾性队列研究。
2001 年 1 月 1 日至 2010 年 12 月 31 日期间,在加拿大安大略省因肾移植失败后开始血液透析治疗的成年患者(年龄≥18 岁)。
患者的临床和人口统计学特征。
12 个月前开始血液透析治疗至 24 个月内动静脉(AV)血管通路建立(瘘或移植物)的比例和时间。
事件发生率和结局预测因素。
我们的队列包括 683 名平均年龄为 48 岁且>50%患者的合并症指数评分<3 的患者。在透析前 12 个月和透析后 24 个月,分别有 16%和 47%的患者建立了 AV 通路。在透析后期间,分别有 13%、26%和 38%的患者在第 3、6 和 12 个月建立了 AV 通路。移植前存在冠状动脉疾病、糖尿病和腹膜透析史与 AV 通路建立的可能性降低相关。
除数据元素之外,无法测量的变量仍存在残余选择偏差。
在安大略省,尽管与整体血液透析人群相比,肾移植失败后开始血液透析治疗的患者更年轻、更健康,但 AV 通路的建立(包括透析前和透析后)仍然很低。这突显了在移植诊所中需要建立透析前护理途径,并积极寻找接受血液透析的这一患者群体,以确定治疗模式和通路选择。